Pyridocarbazole Alkaloids from Ochrosia Borbonica: Lipid-Lowering Agents Inhibit the Cell Proliferation and Adipogenesis of 3T3-L1 Adipocyte Via Intercalating into Supercoiled DNA

Xu Yao-Hao,Li Wei,Rao Yong,Huang Zhi-Shu,Yin Sheng
DOI: https://doi.org/10.1016/s1875-5364(19)30080-9
IF: 3.887
2019-01-01
Chinese Journal of Natural Medicines
Abstract:Bioassay-guided fractionation of an ethanolic extract of Ochrosia borbonica led to the isolation of two known pyridocarbazole alkaloids, ellipticine (1) and 9-methoxyellipticine (2), and six known monoterpenoid indole alkaloids (3–8). Lipid-lowering assay in 3T3-L1 cell model revealed that 1 and 2 could significantly inhibit the lipid droplet formation (EC50 = 0.41 and 0.92 μmol·L−1, respectively) and lower triglyceride levels by 50%–60% at the concentration of 1 μmol·L−1, being more potent than the positive drug luteolin (EC50 = 2.63 μmol·L−1). A mechanistic study indicated that 1 and 2 could intercalate into supercoiled DNA, which consequently inhibited the mitotic clonal expansion of 3T3-L1 cells at the early differentiation phase, leading to the retardance of following adipogenesis and lipogenesis. These findings suggest that 1 and 2 may serve as promising leads for further development of anti-obesity drugs.
What problem does this paper attempt to address?